Author

Carles Pigrau

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Pathology· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Assay:clinical cohort / trial· 1 Research Focus:host-pathogen & immune response· 1 Organism:human· 1 Approach:statistical model· 1

Frequent Co-Authors

Alba Ribera· 1 shared Alejandra Morales-Cartagena· 1 shared Ana Ayestarán· 1 shared Jesús Rodríguez-BañoiD· 1 shared Joaquín Martínez-Montauti· 1 shared Jose Loureiro-Amigo· 1 shared Lucia Ortega· 1 shared Mercedes Clemente· 1 shared

Activity by Year

2018-2018 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 45 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

1 shared paperPathology

Alba Ribera

Mutual co-authors in cluster

Author profile →

1 paper

Recent·Most cited

Non-intravenous, carbapenem-sparing antibiotics for the treatment of bacteremia due to ESBL or AMP-C β-lactamase: A propensity score study

Yolanda Meije, Carles Pigrau, Nuria Fernandez-Hidalgo, Mercedes Clemente, Lucia Ortega, Xavier Sanz, Jose Loureiro-Amigo, Montserrat Sierra, Alejandra Morales-Cartagena, Alba Ribera, Ana Ayestarán, Jesús Rodríguez-Baño, Joaquín Martínez-Montauti

This study compares 30-day mortality and clinical outcomes of carbapenem vs non-intravenous antibiotic treatment for ESBL/Amp-C positive Enterobacteriaceae bacteremia, finding no increased mortality with non-intravenous alternatives.

bioRxiv · Apr 18, 2018 · PreprintPathology